TY  - GEN
AU  - Jameson,Gayle S
AU  - Hamm,John T
AU  - Weiss,Glen J
AU  - Alemany,Carlos
AU  - Anthony,Stephen
AU  - Basche,Michele
AU  - Ramanathan,Ramesh K
AU  - Borad,Mitesh J
AU  - Tibes,Raoul
AU  - Cohn,Allen
AU  - Hinshaw,Ioana
AU  - Jotte,Robert
AU  - Rosen,Lee S
AU  - Hoch,Ute
AU  - Eldon,Michael A
AU  - Medve,Robert
AU  - Schroeder,Katrina
AU  - White,Erica
AU  - Von Hoff,Daniel D
TI  - A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors
SN  - 1557-3265
PY  - 2013///0618
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Female
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Polyethylene Glycols
KW  - Topoisomerase I Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-12-1201
ER  -